- Home
- CVKD vs FCUV Comparison
CVKD vs FCUV Comparison
Compare CVKD & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- FCUV
- Stock Information
- Founded
- CVKD 2022
- FCUV 2012
- Country
- CVKD United States
- FCUV United States
- Employees
- CVKD N/A
- FCUV N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- FCUV Industrial Machinery/Components
- Sector
- CVKD Health Care
- FCUV Industrials
- Exchange
- CVKD Nasdaq
- FCUV Nasdaq
- Market Cap
- CVKD 29.5M
- FCUV 27.6M
- IPO Year
- CVKD 2023
- FCUV N/A
- Fundamental
- Price
- CVKD $12.90
- FCUV $3.91
- Analyst Decision
- CVKD Strong Buy
- FCUV
- Analyst Count
- CVKD 1
- FCUV 0
- Target Price
- CVKD $32.00
- FCUV N/A
- AVG Volume (30 Days)
- CVKD 34.8K
- FCUV 14.0K
- Earning Date
- CVKD 08-06-2025
- FCUV 08-13-2025
- Dividend Yield
- CVKD N/A
- FCUV N/A
- EPS Growth
- CVKD N/A
- FCUV N/A
- EPS
- CVKD N/A
- FCUV N/A
- Revenue
- CVKD N/A
- FCUV $408,887.00
- Revenue This Year
- CVKD N/A
- FCUV N/A
- Revenue Next Year
- CVKD N/A
- FCUV N/A
- P/E Ratio
- CVKD N/A
- FCUV N/A
- Revenue Growth
- CVKD N/A
- FCUV 6.49
- 52 Week Low
- CVKD $5.70
- FCUV $1.50
- 52 Week High
- CVKD $22.90
- FCUV $10.90
- Technical
- Relative Strength Index (RSI)
- CVKD 49.22
- FCUV 45.97
- Support Level
- CVKD $11.00
- FCUV $3.75
- Resistance Level
- CVKD $13.56
- FCUV $4.23
- Average True Range (ATR)
- CVKD 1.13
- FCUV 0.22
- MACD
- CVKD 0.23
- FCUV 0.02
- Stochastic Oscillator
- CVKD 78.32
- FCUV 46.75
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.